Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Clinical Senior Lecturer in Interstitial Lung Disease







Sir Alexander Fleming BuildingSouth Kensington Campus





Dr Philip Molyneaux is a Clinical Senior Lecturer in Interstitial lung disease and an Honorary Consultant at the Royal Brompton Hospital.

Philip qualified from Guy's, King's and St Thomas' School of Medicine in 2004, where he completed an intercalated BSc. in Molecular Genetics. He undertook his SHO training at Guy’s and St Thomas’ and upon completion of the MRCP attained an NIHR Academic Clinical Fellow position in Respiratory medicine at Imperial College. He spent the next two years training at St Mary’s Hospital and working with Professors Cookson, Moffatt and Johnston studying the respiratory microbiome in COPD. 

An Asmarley training fellowship allowed him to undertake a PhD examining the host response to the respiratory microbiome in Idiopathic Pulmonary Fibrosis as part of the Prospective Study of Fibrosis In the Lung Endpoints (PROFILE) study with Professors Maher, Cookson and Moffatt

Having completed his clinical training in Respiratory and Critical Care Medicine he returned to Imperial joining the Fibrosis Research Group as a Senior Clinical Lecturer. He also holds a position as Consultant in Interstitial Lung Disease at the Royal Brompton Hospital where he has a  special interest in Familial Pulmonary Fibrosis.



Garner JL, Garner SD, Hardie RJ, et al., 2019, Evaluation of a re-useable bronchoscopy biosimulator with ventilated lungs, Erj Open Research, Vol:5, Pages:00035-2019

Mackintosh JA, Desai SR, Adamali H, et al., 2019, In Patients with Idiopathic Pulmonary Fibrosis the Presence of Hiatus Hernia is Associated with Disease Progression and Mortality., Eur Respir J

Lukey PT, Harrison SA, Yang S, et al., 2019, A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis., Eur Respir J, Vol:53

Segal LN, Molyneaux PL, 2019, The Challenging Road of Moving from Association to Causation for Microbiome Research in IPF., Am J Respir Crit Care Med

Macaluso C, Furcada JM, Alzaher O, et al., 2019, The potential impact of azithromycin in idiopathic pulmonary fibrosis, European Respiratory Journal, Vol:53, ISSN:0903-1936

More Publications